GTX-101
GTX-101-004
Phase 1 small_molecule active
Quick answer
GTX-101 for Postherpetic Neuralgia is a Phase 1 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Grace Therapeutics
- Indication
- Postherpetic Neuralgia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active